Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab.

Autor: Jeschke M; Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany., Ludwig JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany., Leyh C; Clinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty of Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, 40225 Düsseldorf, Germany., Pabst KM; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.; German Cancer Consortium (DKTK), University Hospital Essen, 45147 Essen, Germany., Weber M; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.; German Cancer Consortium (DKTK), University Hospital Essen, 45147 Essen, Germany., Theysohn JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany., Lange CM; Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany., Herrmann K; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.; German Cancer Consortium (DKTK), University Hospital Essen, 45147 Essen, Germany., Schmidt HH; Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany., Jochheim LS; Department of Gastroenterology, Hepatology and Transplant Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2023 Aug 26; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 26.

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.

Autor: Sinner F; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital Magdeburg, 39120 Magdeburg, Germany., Pinter M; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, A-1090 Vienna, Austria.; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, A-1090 Vienna, Austria., Scheiner B; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, A-1090 Vienna, Austria.; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, A-1090 Vienna, Austria., Ettrich TJ; Ulm University Hospital, Department of Internal Medicine I, 89081 Ulm, Germany., Sturm N; Ulm University Hospital, Department of Internal Medicine I, 89081 Ulm, Germany., Gonzalez-Carmona MA; Department of Internal Medicine I, University Hospital of Bonn, 53127 Bonn, Germany., Waidmann O; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, 60590 Frankfurt, Germany.; University Cancer Center Frankfurt, University Hospital Frankfurt, 60590 Frankfurt, Germany.; Center for Hematology and Oncology Bethanien, 60389 Frankfurt, Germany., Finkelmeier F; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, 60590 Frankfurt, Germany.; University Cancer Center Frankfurt, University Hospital Frankfurt, 60590 Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt/Main, 60590 Frankfurt, Germany., Himmelsbach V; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, 60590 Frankfurt, Germany., De Toni EN; Department of Medicine II, University Hospital, LMU Munich, 81377 Munich, Germany., Ben Khaled N; Department of Medicine II, University Hospital, LMU Munich, 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center, 69120 Heidelberg, Germany., Mohr R; Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Campus Charité Mitte, Charité University Medicine Berlin, 10117 Berlin, Germany., Fründt TW; Department of Internal Medicine, Gastroenterology & Hepatology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Kütting F; Clinic for Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany., Bömmel FV; Department of Medicine II, Division of Hepatology, Leipzig University Medical Center, 04103 Leipzig, Germany., Lieb S; Department of Medicine II, Division of Hepatology, Leipzig University Medical Center, 04103 Leipzig, Germany., Krug S; Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany., Bettinger D; Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Schultheiß M; Department of Medicine II, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Jochheim LS; Department of Gastroenterology and Hepatology, University Hospital Essen, 45147 Essen, Germany., Best J; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital Magdeburg, 39120 Magdeburg, Germany.; Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, 44892 Bochum, Germany., Müller C; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital Magdeburg, 39120 Magdeburg, Germany., Keitel V; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital Magdeburg, 39120 Magdeburg, Germany., Venerito M; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital Magdeburg, 39120 Magdeburg, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 02; Vol. 14 (23). Date of Electronic Publication: 2022 Dec 02.

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.

Autor: de Castro T; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Jochheim LS; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany., Bathon M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Welland S; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Scheiner B; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Shmanko K; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Roessler D; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany., Ben Khaled N; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany., Jeschke M; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany., Ludwig JM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, Faculty of Medicine, Essen University Hospital, Essen, Germany., Marquardt JU; Department of Medicine I, University Hospital Schleswig-Holstein, Lübeck, Germany., Weinmann A; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Pinter M; Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Lange CM; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany., Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany., Saborowski A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Feb 26; Vol. 14, pp. 17588359221080298. Date of Electronic Publication: 2022 Feb 26 (Print Publication: 2022).

The neuropeptide receptor subunit RAMP1 constrains the innate immune response during acute pancreatitis in mice.

Autor: Jochheim LS; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Odysseos G; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Hidalgo-Sastre A; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Zhong S; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Staufer LM; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Kroiss M; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Kabacaoglu D; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Lange S; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich, Germany., Engleitner T; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich, Germany., Hartmann D; Technical University Munich, School of Medicine, Klinikum Rechts der Isar, Department of Surgery, Munich, Germany., Hüser N; Technical University Munich, School of Medicine, Klinikum Rechts der Isar, Department of Surgery, Munich, Germany., Steiger K; Technical University Munich, School of Medicine, Department of Pathology, Munich, Germany., Schmid RM; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Holzmann B; Technical University Munich, School of Medicine, Klinikum Rechts der Isar, Department of Surgery, Munich, Germany., von Figura G; Technical University of Munich, School of Medicine, Klinikum Rechts der Isar, Department of Internal Medicine II, Munich, Germany. Electronic address: gvfigura@tum.de.

Publikováno v: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2019 Jun; Vol. 19 (4), pp. 541-547. Date of Electronic Publication: 2019 May 11.